Open AccessMURINE OKT4A IMMUNOSUPPRESSION IN CADAVER DONOR RENAL ALLOGRAFT RECIPIENTS
Author(s) -
Chronic Kidney Disease and Anaemia In Internal Medicine FADOI Study Group
Publication year - 1997
Publication title -
transplantation
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 1.45
H-Index - 204
eISSN - 1534-6080
pISSN - 0041-1337
DOI - 10.1097/00007890-199705150-00009
Subject(s) - medicine , azathioprine , immunosuppression , creatinine , prednisone , transplantation , urology , surgery , regimen , kidney transplantation , renal function , gastroenterology , kidney , tolerability , adverse effect , disease
A phase I study of anti-CD4 immunosuppression of cadaver donor renal allograft recipients was conducted by the NIH Cooperative Clinical Trials in Transplantation to assess safety, tolerability, immunoactivity, and pharmacokinetics of multiple infusions of murine anti-human CD4 monoclonal antibody OKT4A.